Takeda joins hot molecular glue market with $1.2B deal

cafead

Administrator
Staff member
  • cafead   May 23, 2024 at 12:02: PM
via Riding the growing wave of interest in molecular glue degraders, Takeda has partnered with Chinese biotech Degron Therapeutics to develop novel therapies for oncology, neuroscience and inflammation.

article source